Analysts expect Spero Therapeutics, Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 13.47 M | 15.04 M | 5.87 M | 14.19 M | 5.44 M | 41.30 M | 258,000.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 22.41 M | 12.82 M | 11.00 M | 11.21 M | 11.73 M | 26.19 M | - | - | 0.00 | 0.00 | 0.00 | 0.00 | -3.08 M | 2.35 M | -2.75 M | 420,546.43 | ||||||||||
| Low Estimate | 20.87 M | 10.64 M | 10.03 M | 10.18 M | 10.83 M | 24.21 M | - | - | 0.00 | 0.00 | 0.00 | 0.00 | -3.56 M | 2.09 M | -3.05 M | 390,284.59 | ||||||||||
| Consensus Estimate | 21.64 M | 11.73 M | 10.52 M | 10.69 M | 11.28 M | 25.20 M | - | - | 0.00 | 0.00 | 0.00 | 0.00 | -3.32 M | 2.22 M | -2.90 M | 405,415.51 |
Analysts expect Spero Therapeutics, Inc. to report earnings per share of -0.50 for Q3 26, against a range of -0.53 to -0.47. The most recent reported quarter, Q2 26, came in at -0.16, a 5.9% beat against the -0.17 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.32 | -0.38 | -0.25 | -0.03 | -0.13 | 0.53 | -0.13 | -0.16 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.24 | -0.27 | -0.49 | -0.33 | -0.25 | -0.17 | -0.16 | -0.16 | -0.47 | -0.17 | -0.18 | -0.23 | -0.47 | -0.16 | -0.22 | -0.19 | ||||||||||
| Low Estimate | -0.26 | -0.31 | -0.55 | -0.39 | -0.29 | -0.21 | -0.18 | -0.18 | -0.53 | -0.21 | -0.20 | -0.25 | -0.51 | -0.18 | -0.26 | -0.23 | ||||||||||
| Consensus Estimate | -0.25 | -0.29 | -0.52 | -0.36 | -0.27 | -0.19 | -0.17 | -0.17 | -0.50 | -0.19 | -0.19 | -0.24 | -0.49 | -0.17 | -0.24 | -0.21 |
Pull Wall Street consensus for Spero Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=SPRO&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "SPRO", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=SPRO&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();